• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emergence of Gastrointestinal Basidiobolomycosis in the United States, With a Review of Worldwide Cases

Emily

Editor, Senior Moderator
http://cid.oxfordjournals.org/content/early/2012/03/21/cid.cis250
Emergence of Gastrointestinal Basidiobolomycosis in the United States, With a Review of Worldwide Cases

  1. Holenarasipur R. Vikram1,
  2. Jerry D. Smilack1,
  3. Jonathan A. Leighton2,
  4. Michael D. Crowell2, and
  5. Giovanni De Petris3
- Author Affiliations

  1. <address><sup>1</sup>Division of Infectious Diseases </address>
  2. <address><sup>2</sup>Division of Gastroenterology </address>
  3. <address><sup>3</sup>Division of Anatomic Pathology, Mayo Clinic, Scottsdale, Arizona </address>

  1. Correspondence: Holenarasipur R. Vikram, MD, Division of Infectious Diseases, Mayo Clinic Hospital, 5777 E Mayo Blvd, Phoenix, AZ 85054 .

Abstract

Background. We examined the epidemiology, clinical manifestations, histopathology, management, and outcomes of gastrointestinal basidiobolomycosis, an uncommon manifestation of infection caused by the fungus Basidiobolus ranarum.
[snip]
Results. Of 44 patients (mean age, 37 years [range, 2?81 years]) with gastrointestinal basidiobolomycosis, most were from the United States (19 patients [43%], of whom 17 [89%] were from Arizona) or Saudi Arabia (11 [25%]). Most (28 [64%]) were previously healthy. Common chronic medical conditions among 15 patients (34%) were diabetes mellitus (8 patients [18%]) and gastric disorders (7 [16%]). Common findings were abdominal pain (37 patients [84%]) and a palpable abdominal mass (19 [43%]). Intraabdominal malignancy was the leading provisional diagnosis (19 patients [43%]). The large bowel was involved in 36 (82%), the small intestine in 16 (36%), and the liver or gallbladder in 13 (30%). Characteristic histopathologic findings were observed in 43 (98%). Eight patients (18%) died. Combined surgical intervention and antifungal therapy was the preferred treatment.
Conclusions.Gastrointestinal basidiobolomycosis is an emerging invasive fungal infection in desert regions of the US Southwest. Clinical findings mimic malignancy and inflammatory bowel disease. Surgical excision and prolonged antifungal therapy are associated with favorable outcomes.


  • Received August 12, 2011.
  • Accepted February 16, 2012.

? The Author 2012. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.
 
Back
Top Bottom